ES2061007T3 - Preparacion farmaceutica que contiene proteina-s. - Google Patents

Preparacion farmaceutica que contiene proteina-s.

Info

Publication number
ES2061007T3
ES2061007T3 ES90890184T ES90890184T ES2061007T3 ES 2061007 T3 ES2061007 T3 ES 2061007T3 ES 90890184 T ES90890184 T ES 90890184T ES 90890184 T ES90890184 T ES 90890184T ES 2061007 T3 ES2061007 T3 ES 2061007T3
Authority
ES
Spain
Prior art keywords
pharmaceutical preparation
preparation containing
containing protein
protein
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90890184T
Other languages
English (en)
Inventor
Hans Peter Dr Schwarz
Ewald Dr Molinari
Yendra Dr Linnau
Susanne Dipl-Ing Pfeiler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG filed Critical Immuno AG
Application granted granted Critical
Publication of ES2061007T3 publication Critical patent/ES2061007T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

EL INVENTO SE REFIERE A UN PREPARADO FARMACEUTICO; QUE SE UTILIZA PARA EL TRATAMIENTO O REDUCCION DE TROMBOSIS. TIENE UNA CONCENTRACION EN PROTEINA (S) QUE SUPONE UN CONTENIDO 50 VECES MAYOR DEL CONTENIDO DE PLASMA NATIVO; ESTA LIBRE DE PROTEINA DE C4 Y SE COMBINA CON UN CONTENIDO EN PROTEINA C ACTIVADA.
ES90890184T 1989-06-26 1990-06-18 Preparacion farmaceutica que contiene proteina-s. Expired - Lifetime ES2061007T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0155189A AT402153B (de) 1989-06-26 1989-06-26 Protein-s-hältige pharmazeutische präparation

Publications (1)

Publication Number Publication Date
ES2061007T3 true ES2061007T3 (es) 1994-12-01

Family

ID=3515833

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90890184T Expired - Lifetime ES2061007T3 (es) 1989-06-26 1990-06-18 Preparacion farmaceutica que contiene proteina-s.

Country Status (10)

Country Link
US (1) US5143901A (es)
EP (1) EP0406216B1 (es)
JP (1) JPH0338528A (es)
AT (2) AT402153B (es)
CA (1) CA2019745C (es)
DE (1) DE59003060D1 (es)
DK (1) DK0406216T3 (es)
ES (1) ES2061007T3 (es)
FI (1) FI94927C (es)
NO (1) NO902823L (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US6458360B1 (en) 1990-04-25 2002-10-01 The Johns Hopkins University Soluble complement regulatory molecules
WO1993009807A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Methods of inhibiting thrombosis via elevation of circulating endogenous activated protein c levels
WO1994005692A1 (en) * 1992-08-27 1994-03-17 Stichting Centraal Laboratorium Van De Bloedtransfusiedienst Van Het Nederlandse Rode Kruis Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4418635C2 (de) * 1994-05-27 1997-07-24 Immuno Ag Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen
AU2001238034A1 (en) * 2000-02-04 2001-08-14 The Scripps Research Institute Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc)
JP2023532726A (ja) * 2020-06-29 2023-07-31 インサーム（インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル） 抗プロテインｓシングルドメイン抗体及びそれを含むポリペプチド

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258288A (en) * 1986-07-25 1993-11-02 Genzyme Corporation Vector containing DNA encoding mature human protein S
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
WO1989002747A1 (en) * 1987-10-05 1989-04-06 The American National Red Cross Therapeutic thrombolytic composition

Also Published As

Publication number Publication date
NO902823D0 (no) 1990-06-25
FI94927C (fi) 1995-11-27
NO902823L (no) 1990-12-27
US5143901A (en) 1992-09-01
ATA155189A (de) 1996-07-15
FI94927B (fi) 1995-08-15
AT402153B (de) 1997-02-25
EP0406216B1 (de) 1993-10-13
FI903197A0 (fi) 1990-06-26
CA2019745A1 (en) 1990-12-26
CA2019745C (en) 1996-12-31
EP0406216A3 (en) 1991-02-06
EP0406216A2 (de) 1991-01-02
DE59003060D1 (de) 1993-11-18
ATE95818T1 (de) 1993-10-15
DK0406216T3 (da) 1994-01-17
JPH0338528A (ja) 1991-02-19

Similar Documents

Publication Publication Date Title
DE58903811D1 (de) Vorrichtung zur regelung und/oder anzeige des betriebs von staubsaugern.
ZA908953B (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
SE8802781L (sv) Foerfarande foer avfuktning av gaser
NO894367D0 (no) System og fremgangsmaate for kvantitativ bestemmelse av konsentrasjonene av flere gasser i boreslam.
ES2062355T3 (es) Composicion farmaceutica que comprende loratadina, ibuprofeno y pseudoefedrina.
SE8803486D0 (sv) Dosage form for treating cardiovascular diseases
DE69020862D1 (de) Anlage zur Verabreichung steriler Flüssigkeiten, insbesondere pharmazeutischer, nahrhafter oder energetischer Flüssigkeiten.
GR3006630T3 (es)
KR890011606A (ko) 항응고제
ES2061007T3 (es) Preparacion farmaceutica que contiene proteina-s.
EP0347864A3 (en) Anti-atherogenic agents
ATE69164T1 (de) Arzneimittel zur behandlung von uraemie.
EP0612526A4 (en) ANTI-INFLAMMATORY AND ANALGESIC PLATTER.
ES2055163T3 (es) Utilizacion del cofactor-enzima nadph para la preparacion de un medicamento asi como el medicamento preparado de este modo y procedimiento para su preparacion.
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
KR880009661A (ko) 궤양성 대장염치료를 위한 사람의 혈액응고인자 xiii의 용도
IL95849A0 (en) Pharmaceutical combination containing acetylsalicylic acid and carbacyclin derivatives
DE69331008D1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
MX9201825A (es) Composicion farmaceutica que contiene calcitonina.
SE8900564D0 (sv) Novel medicinal use
EP0351790A3 (de) Verfahren zur Bestimmung von Fructosamin
DE58908696D1 (de) Vorrichtung zur Feststellung des Alkoholgehaltes und/oder des Heizwertes von Kraftstoffen.
IL68422A0 (en) Hydantoin derivatives and their use in medicine
KR900012622A (ko) 피부질환치료 조성물
KR900015747A (ko) 간장관련 질병 치료제의 제조방법

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 406216

Country of ref document: ES